ReneuBio
PrivateLast Round
Seed
Feb 1, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ReneuBio operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Pre Seed round in November 2025.
ReneuBio is a drug discovery company developing small molecules to restore the regenerative capacity of the aging brain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReneuBio Comparables
Compare ReneuBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Renue Life Sciences, Inc. | 86% | |
| Shift Bioscience | 75% | |
| 4M Therapeutics | 74% |
For institutional investors. Book with your work email.
ReneuBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2026 | ||||
| Pre Seed | Nov 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
$8M raised in Seed round.
- Nov 27, 2024
Grew 100% QoQ from 3 to 6 employees.
For institutional investors. Book with your work email.
ReneuBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ReneuBio's valuation, stock price, and market status.
Is ReneuBio a public or private company?
ReneuBio is a private company.
What is the current stock price of ReneuBio?
ReneuBio is a private company, so its shares have no public market price. Caplight tracks ReneuBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ReneuBio worth (valuation)?
Valuation information for ReneuBio is not publicly available.
Can I buy ReneuBio stock?
ReneuBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ReneuBio's last funding round?
ReneuBio's most recent funding round was Seed on February 1, 2026.
Who are the main investors in ReneuBio?
Investor information for ReneuBio is not publicly disclosed.
Will ReneuBio IPO soon?
No public IPO plans have been announced for ReneuBio.
How can I track ReneuBio secondary market activity?
Caplight tracks bids, offers, and trades in ReneuBio's shares on secondary markets.